HANTSON LUDWIG (CEO) received a stock award from ALEXION PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 7/16/2021ACC: 0000899866-21-000058
DirectorOfficer· CEO
Since Dec 2018
+240.74K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
240.74K acquired
Non-Derivative Transactions2
Common Stock, par value $.0001 per share
Direct
Shares
+120.89K
Price / share
—
Trade value
—
% of position
34.6%
7/14/2021
349.17K→470.06K
Common Stock, par value $.0001 per share
Direct
Shares
+119.85K
Price / share
—
Trade value
—
% of position
25.5%
7/14/2021
470.06K→589.91K
Total
Net shares
+240.74K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per share Direct | 7/14/2021 | A · Award | +120.89K | — | — | 34.6% | 349.17K | 470.06K |
| Common Stock, par value $.0001 per share Direct | 7/14/2021 | A · Award | +119.85K | — | — | 25.5% | 470.06K | 589.91K |
| Total | +240.74K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported